Mutations in chromatin machinery and pediatric high-grade glioma

Rishi R Lulla, Amanda Muhs Saratsis, Rintaro Hashizume*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations


Pediatric central nervous system tumors are the most common solid tumor of childhood. Of these, approximately one-third are gliomas that exhibit diverse biological behaviors in the unique context of the developing nervous system. Although low-grade gliomas predominate and have favorable outcomes, up to 20% of pediatric gliomas are high-grade. These tumors are a major contributor to cancer-related morbidity and mortality in infants, children, and adolescents, with long-term survival rates of only 10 to 15%. The recent discovery of somatic oncogenic mutations affecting chromatin regulation in pediatric high-grade glioma has markedly improved our understanding of disease pathogenesis, and these findings have stimulated the development of novel therapeutic approaches targeting epigenetic regulators for disease treatment. We review the current perspective on pediatric high-grade glioma genetics and epigenetics, and discuss the emerging and experimental therapeutics targeting the unique molecular abnormalities present in these deadly childhood brain tumors.

Original languageEnglish (US)
Article numbere1501354
JournalScience Advances
Issue number3
StatePublished - Mar 1 2016

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Mutations in chromatin machinery and pediatric high-grade glioma'. Together they form a unique fingerprint.

Cite this